Project Grant R01HL173334
Award Date
9/5/24
Completion Date
5/31/29
Dollars Obligated
$598K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA Program 93.837 Cardiovascular Diseases Research) provides $480,990 to the University of Illinois to conduct research on the role of aerocytes, a recently identified capillary endothelial cell population, in regulating alveolar regeneration following lung injury. The research aims to establish the central role of aerocytes and the signaling molecule R-spondin3 in guiding regenerative alveolar remodeling, with the...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $762,405.80 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the University of South Alabama. The grant, which runs from August 1, 2024 to July 31, 2027, supports research to investigate the role of the cell-free hemoglobin-oxidized LDL-LOX-1 axis in driving microvascular hyperpermeability and lung injury during sepsis. The project aims to elucidate the cellular and molecular mechanisms by which...
This $739,362 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate a novel genetic variant in the COQ6 gene and its role in increasing susceptibility to Streptococcus pneumoniae sepsis. The research aims to re-evaluate the immune-centric model of sepsis by exploring how this genetic variant disrupts mitochondrial function and metabolic remodeling, leading to hyperinflammation and organ damage. The...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $759,983.00 to the University of North Carolina at Chapel Hill to investigate neutrophil function and the lung microenvironment during Streptococcus pneumoniae pneumonia and acute lung injury. The study aims to determine how neutrophils change as they are recruited and function during pneumonia, compare neutrophils defined by specific criteria, and examine changes...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $392,660 to The Trustees of the University of Pennsylvania to investigate the role of red blood cells (RBCs) in regulating the inflammatory response during sepsis. The study aims to establish the subcellular localization of Toll-like receptor 7 (TLR7) in human RBCs, determine RBC-TLR7's RNA-sequestration capabilities during sepsis, and define the...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $511,680 Project Grant to the University of Illinois under the Cardiovascular Diseases Research program (CFDA 93.837). The grant will fund research from February 2021 through August 2021 to investigate mechanisms by which vascular endothelial cells instruct macrophage fate in inflammatory injury. Specifically, the research will examine how endothelial cell Wnt signaling licenses the differentiation of monocytes...
This Project Grant award, identified as R01HL170118, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The award, totaling $495,159.00, will fund research to investigate the role of the protein CARMIL1 in regulating endothelial cell barrier function and its potential impact on acute respiratory distress syndrome (ARDS). The study, to be conducted by the University of Illinois, will use...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,659,996 to the University of Southern California (USC) to conduct research on the role of the protein PDLIM2 in regulating alveolar macrophages and their function in lung innate immunity, inflammation, and diseases. The key objectives are to determine the physiological and pathophysiological significance of the PDLIM2/CD80/PD-L1 signaling pathway in alveolar...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,147,992 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at improving outcomes for patients with acute respiratory distress syndrome (ARDS) and sepsis. The research focuses on identifying molecular phenotypes of these syndromes and understanding the underlying biological pathways and...
This federal Project Grant award of $479,249, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to study the molecular mechanisms regulating neutrophil proinflammatory activity in sepsis. The key objectives are to: Determine the molecular basis of neutrophil A20 signaling in regulating neutrophil proinflammatory function under septic conditions. Utilize two-photon intravital...